B2M and neoplasm: Allografted tumors were established using the B2M KO lines in wild-type C57BL/6 mice, and these tumor models were utilized to evaluate the efficacy of mIL12 mRNA in experiments analogous to the unmodified Yummer 1.7 and MC38 parental tumor models.